|
|
| C-005 / Wuxi Shuangliang Biotech (0 Trials) |
|
| C-122 / Corridor Pharma (0 Trials) |
|
| C-13-60 / Chongqing Precision Biotech (0 Trials) |
|
| C-13-90 / Chongqing Precision Biotech (0 Trials) |
|
| C-4-29 / Chongqing Precision Biotech (0 Trials) |
|
| C-82 Topical Gel, 1% / PRISM Pharma (0 Trials) |
|
| c-bcl-2 modulator / MuriGen (0 Trials) |
|
| C-CAR011 / AbelZeta Pharma (7 Trials) |
|
| C-CAR088 / AbelZeta Pharma (0 Trials) |
|
| C-Cure (human adult BM-derived somatic cell therapy) / Celyad Oncology (0 Trials) |
|
| c-KIT CAR-T / Sorrento (0 Trials) |
|
| c-Met inhibitor / Wakunaga (0 Trials) |
|
| C-peptide (SPM 933) / UCB (0 Trials) |
|
| C-TCR055 / Cellular Biomedicine (0 Trials) |
|
| C-TIL051 / AbelZeta Pharma (0 Trials) |
|
| C-TIL052A / Cellular Biomedicine (0 Trials) |
|
| C-TPS1 based cell therapy / iCell Gene Therap (0 Trials) |
|
| C0021158 / AstraZeneca, Cancer Research UK (0 Trials) |
|
| C019199 / Fujian Haixi New Pharmaceutical (0 Trials) |
|
| C1-AAT / Kamada (0 Trials) |
|
| C1-INH / Liminal BioSci (0 Trials) |
|
| C101248 / Cerevance (0 Trials) |
|
| C106 / Vicore Pharma (0 Trials) |
|
| C144-LS / BMS (0 Trials) |
|
| C19-IG 20% / Grifols (0 Trials) |
|
| C1C62-M3M4 / University of North Carolina-Chapel Hill, National Institute of Allergy and Infectious Diseases (0 Trials) |
|
| C2-2b-2b dock-and-lock / Gilead (0 Trials) |
|
| C326 / Amgen (0 Trials) |
|
| C3BS-CQR-1 / Celyad Oncology (0 Trials) |
|
| C4X-6746 / AstraZeneca (0 Trials) |
|
| C6-17 / AFFiRiS (0 Trials) |
|
| C62-M4 / University of North Carolina-Chapel Hill, National Institute of Allergy and Infectious Diseases (0 Trials) |
|
| C7R-GD2.CART cells / Baylor College of Medicine (0 Trials) |
|
| C9ORF72-ALS therapeutic / Locana (0 Trials) |
|
| CA-170 / Curis (0 Trials) |
|
| CA-327 / Curis (0 Trials) |
|
| CA-IL12 / Cytonus Therap (0 Trials) |
|
| CA-OV-VSV / Cytonus Therap (0 Trials) |
|
| CA002 / Camallergy (0 Trials) |
|
| CA1 / ConverGene (0 Trials) |
|
| CA1 / Shanghai Junshi Biosci, Eli Lilly (0 Trials) |
|
| CA102N / Holy Stone Healthcare (0 Trials) |
|
| CA2 / ConverGene (0 Trials) |
|
| CA21 / Merck (MSD) (0 Trials) |
|
| CA3 / UT MD Anderson Cancer Center (0 Trials) |
|
| CA9hu-1 / Mabpro (0 Trials) |
|
| CAB051 / Biotecnol (0 Trials) |
|
| Cabaletta (trehalose) / Seelos Therap (0 Trials) |
|
| cabamiquine (M5717) / EMD Serono (0 Trials) |
|
| cabazitaxel / Generic mfg. (44 Trials) |
|
| cabazitaxel injection (BH002) / Zhuhai Beihai Biotech (0 Trials) |
|
| cabazitaxel-loaded mixed polymeric micelle (MPB-1734) / MegaPro Biomedical (0 Trials) |
|
| Cabenuva (cabotegravir long acting/rilpivirine long acting) / J&J, GSK, ViiV Healthcare, Pfizer, Shionogi (0 Trials) |
|
| cabergoline / Generic mfg. (18 Trials) |
|
| cabiralizumab (BMS-986227) / Ono Pharma, BMS (2 Trials) |
|
| Cablivi (caplacizumab-yhdp) / Sanofi (9 Trials) |
|
| Cabometyx (cabozantinib tablet) / Exelixis (145 Trials) |
|
| cabotamig (ARB202) / Arbele (0 Trials) |
|
| cabotegravir/recombinant human hyaluronidase PH20 (CAB/rHuPH20) / GSK, ViiV Healthcare (0 Trials) |
|
| Cabtreo (benzoyl peroxide/clindamycin/adapalene) / Bausch Health (0 Trials) |
|
| CAD204520 / Cado Biotech (0 Trials) |
|
| Cadalimab (adalimumab biosimilar) / Cadila (0 Trials) |
|
| cadazolid (ACT-179811) / J&J (0 Trials) |
|
| cadisegliatin (TTP399) / vTv Therapeutics (1 Trials) |
|
| cafelkibart (LM-108) / LaNova Medicines Limited (0 Trials) |
|
| caffeine/naproxen (BAY2880376) / Bayer (0 Trials) |
|
| caficrestat (AT-001) / Applied Therap (0 Trials) |
|
| caflanone (FBL-03G) / Flavocure Biotech (0 Trials) |
|
| cafusertib / Jiangsu Hansoh Pharma (2 Trials) |
|
| cagrilintide (AM833) / Novo Nordisk (3 Trials) |
|
| Cal 1-modified HSPC / CSL Behring (2 Trials) |
|
| CAL-130 / Gilead (0 Trials) |
|
| CAL-263 / Gilead (0 Trials) |
|
| CAL-4 / Calyxha (0 Trials) |
|
| CAL02 / Eagle Pharma (0 Trials) |
|
| CAL101 / Calluna Pharma (0 Trials) |
|
| CALAA-02 / Arrowhead (0 Trials) |
|
| calcaftor / Calista Therap (0 Trials) |
|
| calcifediol / Generic mfg. (9 Trials) |
|
| calcipotriol (AKP01) / Lipidor (1 Trials) |
|
| calcipotriol (P-3073) / Almirall (1 Trials) |
|
| calcipotriol spray (CD 2027) / Nestle (1 Trials) |
|
| calcipotriol/betamethasone dipropionate / Generic mfg. (11 Trials) |
|
| calcipotriol/niacinamide (DPS 101) / DermiPsor (0 Trials) |
|
| Calcitonin gene-related peptide / Akela (0 Trials) |
|
| calcitonin/benzyl alcohol/phenyl ethyl alcohol/aqueous buffer / Generic mfg. (4 Trials) |
|
| calcitonin/glucocorticoid combination therapies (sCT-GC combination therapy) / Enteris (0 Trials) |
|
| calcitriol (BPM 31543) / BPGbio (0 Trials) |
|
| calcium dobesilate monohydrate / Generic mfg. (15 Trials) |
|
| Calcium Lactate (calcium lactate pentahydrate) / Remedica (0 Trials) |
|
| calcium lactate (OMT-111) / MetiMedi Pharma (0 Trials) |
|
| Calcort (deflazacort) / Sanofi (0 Trials) |
|
| Caldolor (ibuprofen) / Grifols, Cumberland (1 Trials) |
|
| Calfine (CCM/Mg/Zn/Vit D3) / VHB Life Sci (0 Trials) |
|
| Calfine plus Junior (calcium carbonate, vit d3) / VHB Life Sci (0 Trials) |
|
| calotatug ginistinag (XMT-2056) / Mersana, GSK (0 Trials) |
|
| Calquence (acalabrutinib) / AstraZeneca (97 Trials) |
|
| Calsed (amrubicin) / BMS, Nippon Kayaku (3 Trials) |
|
| CALY-001 / Eisai (0 Trials) |
|
| CALY-002 / Calypso Biotech (0 Trials) |
|
| CAM-H2 / Precirix (0 Trials) |
|
| cam1615SS1 / GT Biopharma (0 Trials) |
|
| Cam2020 M2SR H3N2 monovalent influenza vaccine / FluGen (0 Trials) |
|
| camB7-H3 CAR T / Fate Therap (0 Trials) |
|
| cambritaxestat (IOA-289) / iOnctura (0 Trials) |
|
| Camcevi 42 mg (leuprolide 6-month depot) / Foresee Pharma, Intas (0 Trials) |
|
| Cametor (cetilistat) / Norgine (0 Trials) |
|
| camicinal (GSK962040) / GSK (0 Trials) |
|
| camidanlumab tesirine (ADCT-301) / Genmab, ADC Therapeutics (3 Trials) |
|
| camizestrant (AZD9833) / AstraZeneca (0 Trials) |
|
| Camligo (alicaforsen rectal) / Ionis, Atlantic Healthcare (0 Trials) |
|
| camlipixant (GSK5464714) / GSK (0 Trials) |
|
| camlipixant extended release (BLU-5937 extended release) / GSK (0 Trials) |
|
| camonsertib (RP-3500) / Repare Therap (0 Trials) |
|
| camostat (QAU145) / Novartis (0 Trials) |
|
| camostat mesilate / Generic mfg. (4 Trials) |
|
| camoteskimab (AVTX-007) / Apollo Therap (1 Trials) |
|
| Campath (alemtuzumab) / Sanofi (64 Trials) |
|
| CampbellCell / Campbell Neurosciences (0 Trials) |
|
| Camposomes (camptothecin nanosomal) / Aphios (0 Trials) |
|
| Campral EC (acamprosate delayed release) / EMD Serono, Nippon Shinyaku (3 Trials) |
|
| camptothecin/fleximer conjugate (XMT-1001) / Mersana (0 Trials) |
|
| camptothecin/podophyllotoxin (NEV-801) / Neovia Oncology (1 Trials) |
|
| camsirubicin (MNPR-201) / Monopar Therap (1 Trials) |
|
| Camtobell (belotecan) / Equisnzaroo (0 Trials) |
|
| Camzyos (mavacamten) / BMS (4 Trials) |
|
| CAN-3110 / Candel Therap (0 Trials) |
|
| CAN10 / Cantargia (0 Trials) |
|
| CAN1012 / Canwell Biotech (0 Trials) |
|
| CAN103 / CANbridge Pharma (0 Trials) |
|
| CAN105 / CANbridge Pharma, WuXi AppTec (0 Trials) |
|
| CAN201 / CANbridge Pharma (0 Trials) |
|
| CAN202 / CANbridge Pharma (0 Trials) |
|
| Canalia (teneligliptin/canagliflozin) / Mitsubishi Tanabe, Daiichi Sankyo (0 Trials) |
|
| Cancelex / Moexa Pharma (0 Trials) |
|
| cancer related fatigue therapy / Legacy Healthcare (0 Trials) |
|
| Cancer testis antigen modulator / A2 Biotherap (0 Trials) |
|
| Cancer therapeutic / Ergon Pharma (0 Trials) |
|
| cancer therapeutics / Veana Therap (0 Trials) |
|
| CanChew Rx (cannabidiol chewing gum) / Axim Biotech (0 Trials) |
|
| candesartan cilexetil / Generic mfg. (34 Trials) |
|
| candida vaccine (PEV7) / Pevion (0 Trials) |
|
| Candidate 1 for Pain / Grunenthal (0 Trials) |
|
| Candidate 2 for painful inflammatory diseases / Grunenthal (0 Trials) |
|
| Candidate 3 for pain / Grunenthal (0 Trials) |
|
| Candidate 4 for painful inflammatory diseases / Grunenthal (0 Trials) |
|
| canerpaturev (TBI-1401) / Takara (1 Trials) |
|
| canertinib (CI-1033) / Pfizer (0 Trials) |
|
| cannabidiol (BRCX014) / Diverse Biotech (0 Trials) |
|
| cannabidiol (BTX 1702) / Botanix Pharma (0 Trials) |
|
| cannabidiol (CBD) / Claritas Pharma (2 Trials) |
|
| cannabidiol (CBD) / Pure Green (0 Trials) |
|
| cannabidiol (CHI-554) / Canopy Growth (0 Trials) |
|
| cannabidiol (DehydraTECH-CBD) / Lexaria Biosci (0 Trials) |
|
| cannabidiol (EMD-RX5) / Emyria (0 Trials) |
|
| cannabidiol (NB23R1) / University of Mississippi Medical Center, Skye Biosci (0 Trials) |
|
| cannabidiol (PTL101) / Harvest One Cannabis (0 Trials) |
|
| cannabidiol (SER-228) / Serina Therap (0 Trials) |
|
| cannabidiol 3% cream (AVCN583601) / Avicanna (0 Trials) |
|
| cannabidiol cream (medical grade cannabis ointment) / OWC Pharma (0 Trials) |
|
| cannabidiol high-dose (EMD-RX7) / Emyria (0 Trials) |
|
| cannabidiol oil capsules / Tilray (0 Trials) |
|
| cannabidiol oral solution (RAD011) / Radius, Benuvia Therap (6 Trials) |
|
| cannabidiol oral strip (CBD ODF) / BioNxt (0 Trials) |
|
| cannabidiol SNAC capsule (RLS102) / Receptor Life Sci (0 Trials) |
|
| cannabidiol solution (ST-101) / Stero Biotechs (0 Trials) |
|
| Cannabidiol Technosphere (cannabidiol inhalation powder) / Receptor Life Sci (0 Trials) |
|
| cannabidiol transdermal gel (BTX1204) / Botanix Pharma (0 Trials) |
|
| cannabidiol transdermal gel (BTX1503) / Botanix Pharma (0 Trials) |
|
| cannabidiol valine hemisuccinate (CBDVHS) / Skye Biosci (0 Trials) |
|
| cannabidiol-loaded exosomes (ICLX) / Innocan Pharma (0 Trials) |
|
| cannabidiol-loaded liposomes / Innocan Pharma (0 Trials) |
|
| cannabidiol/ tetrahydrocannabinol (PG-OA-5TH) / Pure Green (0 Trials) |
|
| cannabidiol/aspatame (JW-200) / Jupiter Wellness (0 Trials) |
|
| cannabidiol/cannabinol (PG-OA-10CN) / Pure Green (0 Trials) |
|
| cannabidiol/delta-9-tetrahydrocannabivarin (GW42004) / Jazz (0 Trials) |
|
| cannabidiol/dronabinol (GWP42002/GWP42003) / Jazz (0 Trials) |
|
| cannabidiol/hydroxychloroquine (IHL-675A) / Incannex (0 Trials) |
|
| cannabidiol/isoflurane (IHL-216A) / Incannex (0 Trials) |
|
| cannabidiol/omega-3 (CQ-001) / CanaQuest (0 Trials) |
|
| cannabidiol/tetrahydrocannabinol / Ethicann Pharma (0 Trials) |
|
| cannabidiol/tetrahydrocannabinol (Accordion Pill Cannabidiol/Tetrahydrocannabinol) / Jazz, Indaptus Therap (0 Trials) |
|
| cannabidiol/tetrahydrocannabinol (EP1) / Cann Pharma (0 Trials) |
|
| cannabidiol/tetrahydrocannabinol (T2:C100) / MediPharm Labs, University of Southern California (0 Trials) |
|
| cannabidiol/tetramethylpyrazine cocrystal (ART12.11) / Artelo Biosci (0 Trials) |
|
| cannabidiolic acid (RSBT-001) / Real Science Holdco (0 Trials) |
|
| cannabidivarin (GWP42006) / Jazz (2 Trials) |
|
| cannabidivarin/cannabigerolic acid (CNBX RCC-33) / CNBX Pharma (0 Trials) |
|
| cannabigerol (CBG) / CNBX Pharma (0 Trials) |
|
| cannabigerol/quercitin / BioNxt (0 Trials) |
|
| cannabinoid based COVID-19 treatment / Avicanna (0 Trials) |
|
| cannabinoid based drug therapy / Applied Botanics, Jupiter Wellness (0 Trials) |
|
| cannabinoid based therapeutic / Curtin University, Zelira (0 Trials) |
|
| cannabinoid based therapeutic for brain cancer / Zelira (0 Trials) |
|
| cannabinoid based therapeutic for breast cancer / Zelira, Complutense University of Madrid (0 Trials) |
|
| cannabinoid based therapeutic for pancreatic cancer / Zelira, Curtin University (0 Trials) |
|
| cannabinoid for COPD / InMed Pharma (0 Trials) |
|
| cannabinoid infused topical ointment (EV102) / Enveric Biosci (0 Trials) |
|
| cannabinoid receptor agonist / Boston Scientific (0 Trials) |
|
| cannabinoid therapeutic / Pascal Biosci (0 Trials) |
|
|